BiomeSense
Pre-clinicalBiomeSense develops advanced microbiome analytics technology to transform healthcare, research, and diagnostics with real-time insights.
Founded
2019
Focus
Microbiome
About
BiomeSense develops advanced microbiome analytics technology to transform healthcare, research, and diagnostics with real-time insights.
Funding History
2Total raised: $15.1M
Series A$12MUndisclosedNov 15, 2022
Seed$3.1MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2019
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile